BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 18586689)

  • 1. Epigenetic silencing of claudin-6 promotes anchorage-independent growth of breast carcinoma cells.
    Osanai M; Murata M; Chiba H; Kojima T; Sawada N
    Cancer Sci; 2007 Oct; 98(10):1557-62. PubMed ID: 17645772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-steroidal anti-inflammatory drugs inhibit calpain activity and membrane localization of calpain 2 protease.
    Silver K; Leloup L; Freeman LC; Wells A; Lillich JD
    Int J Biochem Cell Biol; 2010 Dec; 42(12):2030-6. PubMed ID: 20854926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct Local and Systemic Molecular Signatures in the Esophageal and Gastric Cancers: Possible Therapy Targets and Biomarkers for Gastric Cancer.
    Bednarz-Misa I; Fortuna P; Diakowska D; Jamrozik N; Krzystek-Korpacka M
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32630408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Claudin-2: Roles beyond Permeability Functions.
    Venugopal S; Anwer S; Szászi K
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31726679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Mechanism for Various Pharmacological Activities of NSAIDS.
    Mizushima T
    Pharmaceuticals (Basel); 2010 May; 3(5):1614-1636. PubMed ID: 27713320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of cytotoxic action of crambescidin-816 on human liver-derived tumour cells.
    Rubiolo JA; López-Alonso H; Roel M; Vieytes MR; Thomas O; Ternon E; Vega FV; Botana LM
    Br J Pharmacol; 2014 Apr; 171(7):1655-67. PubMed ID: 24328908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of CLDN1 in gastric cancer is correlated with reduced survival.
    Eftang LL; Esbensen Y; Tannæs TM; Blom GP; Bukholm IR; Bukholm G
    BMC Cancer; 2013 Dec; 13():586. PubMed ID: 24321518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Claudin-2 expression increases tumorigenicity of colon cancer cells: role of epidermal growth factor receptor activation.
    Dhawan P; Ahmad R; Chaturvedi R; Smith JJ; Midha R; Mittal MK; Krishnan M; Chen X; Eschrich S; Yeatman TJ; Harris RC; Washington MK; Wilson KT; Beauchamp RD; Singh AB
    Oncogene; 2011 Jul; 30(29):3234-47. PubMed ID: 21383692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Claudin and occludin expression and function in the seminiferous epithelium.
    Morrow CM; Mruk D; Cheng CY; Hess RA
    Philos Trans R Soc Lond B Biol Sci; 2010 May; 365(1546):1679-96. PubMed ID: 20403878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symplekin promotes tumorigenicity by up-regulating claudin-2 expression.
    Buchert M; Papin M; Bonnans C; Darido C; Raye WS; Garambois V; Pélegrin A; Bourgaux JF; Pannequin J; Joubert D; Hollande F
    Proc Natl Acad Sci U S A; 2010 Feb; 107(6):2628-33. PubMed ID: 20133805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocyte nuclear factor 4alpha, a key factor for homeostasis, cell architecture, and barrier function of the adult intestinal epithelium.
    Cattin AL; Le Beyec J; Barreau F; Saint-Just S; Houllier A; Gonzalez FJ; Robine S; Pinçon-Raymond M; Cardot P; Lacasa M; Ribeiro A
    Mol Cell Biol; 2009 Dec; 29(23):6294-308. PubMed ID: 19805521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-induced alterations to gene and protein expression in intestinal epithelial cell 6 cells suggest a role for calpains in the gastrointestinal toxicity of nonsteroidal anti-inflammatory agents.
    Raveendran NN; Silver K; Freeman LC; Narvaez D; Weng K; Ganta S; Lillich JD
    J Pharmacol Exp Ther; 2008 May; 325(2):389-99. PubMed ID: 18281595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of both COX-1 and COX-2 and resulting decrease in the level of prostaglandins E2 is responsible for non-steroidal anti-inflammatory drug (NSAID)-dependent exacerbation of colitis.
    Tanaka K; Suemasu S; Ishihara T; Tasaka Y; Arai Y; Mizushima T
    Eur J Pharmacol; 2009 Jan; 603(1-3):120-32. PubMed ID: 19101538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NF-kappaB, macrophage migration inhibitory factor and cyclooxygenase-inhibitions as likely mechanisms behind the acetaminophen- and NSAID-prevention of the ovarian cancer.
    Altinoz MA; Korkmaz R
    Neoplasma; 2004; 51(4):239-47. PubMed ID: 15254653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioprotection: the non-steroidal anti-inflammatory drugs (NSAIDs) and prostaglandins.
    Lee TK; Stupans I
    J Pharm Pharmacol; 2002 Nov; 54(11):1435-45. PubMed ID: 12495545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NSAIDs suppress the expression of claudin-2 to promote invasion activity of cancer cells.
    Mima S; Takehara M; Takada H; Nishimura T; Hoshino T; Mizushima T
    Carcinogenesis; 2008 Oct; 29(10):1994-2000. PubMed ID: 18586689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of claudin-4 by nonsteroidal anti-inflammatory drugs and its contribution to their chemopreventive effect.
    Mima S; Tsutsumi S; Ushijima H; Takeda M; Fukuda I; Yokomizo K; Suzuki K; Sano K; Nakanishi T; Tomisato W; Tsuchiya T; Mizushima T
    Cancer Res; 2005 Mar; 65(5):1868-76. PubMed ID: 15753385
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.